**Core Concept**
Von Willebrand disease (VWD) is a congenital bleeding disorder characterized by a deficiency or dysfunction of von Willebrand factor (VWF), a glycoprotein essential for platelet adhesion and coagulation. VWF serves as a carrier protein for factor VIII, protecting it from degradation, and also mediates platelet adhesion to sites of vascular injury.

**Why the Correct Answer is Right**
The correct answer reflects the characteristic laboratory findings in VWD. **Option A: | BT and | PTT** is correct because individuals with VWD typically exhibit prolonged bleeding times (BT) due to impaired platelet adhesion and prolonged partial thromboplastin times (PTT) due to decreased factor VIII activity. This is because VWF acts as a carrier protein for factor VIII, and its deficiency or dysfunction leads to decreased levels of functional factor VIII. The **|** symbol indicates a decrease or prolongation of the respective laboratory parameter.

**Why Each Wrong Option is Incorrect**
**Option B:** Incorrect because PT (prothrombin time) is typically normal in VWD, as the disease primarily affects the intrinsic coagulation pathway, not the extrinsic pathway measured by PT.
**Option C:** Incorrect because isolated prolongation of PT is not characteristic of VWD, which mainly affects the intrinsic coagulation pathway.
**Option D:** Incorrect because CT (clotting time) is not a standard test for VWD, and its relevance to this condition is limited.

**Clinical Pearl / High-Yield Fact**
In VWD, the presence of a prolonged bleeding time (BT) in conjunction with a normal PT and thrombin time (TT) can help differentiate it from other bleeding disorders. This is a critical clinical correlation that can aid in the diagnosis of VWD.

**✓ Correct Answer: A. | BT and | PTT**